Active immunization in HIV-infected patients.
Patients infected with human immunodeficiency virus (HIV) are at risk for various viral and bacterial infections. Active immunization with currently available vaccines may reduce the risk of some vaccine-preventable diseases in this population. Based on available data, most vaccines used in the United States are safe in HIV-infected adults and children. Their clinical efficacy in these individuals is not well defined, although it appears that patients in the earlier stages of infection are more likely to mount a protective antibody response than those in the later stages. Current guidelines for vaccination in HIV-infected children and adults in the United States have been recommended by the Advisory Committee on Immunization Practices.
Pau
A K
AK
Department of Pharmacy Practice, College of Pharmacy, Chicago, Illinois 60612, USA.
McNicholl
I R
IR
Pursell
K J
KJ
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D018073:Haemophilus Vaccines / Q000627:therapeutic use; D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000517:prevention & control; D014611:Vaccination / Q000009:adverse effects
D018073:Haemophilus Vaccines; D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines